title: Beneficial hepatic effect of troglitazone in a patient with antimitochondrial antibody-negative primary biliary cirrhosis.
authors.forename: Takashi
authors.initials: T
authors.lastname: Okai
authors.forename: Hisatsugu
authors.initials: H
authors.lastname: Mouri
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Yamaguchi
authors.forename: Yasuni
authors.initials: Y
authors.lastname: Nakanuma
authors.forename: Norio
authors.initials: N
authors.lastname: Sawabu
mesh_terms: D001323:Autoantibodies / Q000276:immunology; D002839:Chromans / Q000008:administration & dosage*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D008105:Liver Cirrhosis, Biliary / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D008875:Middle Aged; D008928:Mitochondria / Q000276:immunology; D013844:Thiazoles / Q000008:administration & dosage*; D045162:Thiazolidinediones; D016896:Treatment Outcome; D000077288:Troglitazone
chemical_list: D001323:Autoantibodies; D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone